Beta lactams antibiotics ranked far ahead of others, accounting for 50.99% of the consumption sum of total anti-infectives.
内酰胺类销售金额遥遥领先,平均占抗感染药销售金额的50.99%。
This invention relates to novel lactams having the Formula (I): to their pharmaceutical compositions and to their methods of use.
本发明涉及具有式(I)的新的内酰胺、它们的药用组合物和它们的使用方法。
Objective To evaluate the new pharmacokinetic parameter, the duration of time that serum concentrations exceed the MIC(T > MIC)for beta - lactams.
对臼-内酰胺类抗生素的新的药动学参数,“超过MIC的时间”进行评价。
Objective To evaluate the new pharmacokinetic parameter, the duration of time that serum concentrations exceed the MIC(T > MIC)for beta - lactams.
对臼-内酰胺类抗生素的新的药动学参数,“超过MIC的时间”进行评价。
应用推荐